Skip to content

Clinical trials

Phase 3 Anxiety Disorders trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anxiety Disorders Phase: Phase 3 Country / region: United States Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20034
20049
20057
20069
20071
20087
20092
20105
20114
20123
20133
20141
20152
20161
20171
20212
20221
20231
20242
20252
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting7
Active, not recruiting5
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
AstraZeneca5
Eli Lilly and Company5
Massachusetts General Hospital3
Sanofi3
Takeda3
University of Pennsylvania3
Alliance for Clinical Trials in Oncology2
Cephalon2
Jazz Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anxiety Disorders74
Generalized Anxiety Disorder22
Stress Disorders, Post-Traumatic9
Phobia, Social7
Mental Disorders4
Major Depressive Disorder3
Mood Disorders3
Phobic Disorders3
Anxiety, Separation2
Attention Deficit Disorder with Hyperactivity2

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.